Lightcalls.com
 

If the announcement is real the fir...

If the announcement is real the first cloned human baby will be born in November.

A woman in a controversial human cloning program was eight weeks pregnant forward April 3, claims embryologist Dr Severino Antinori, president of the Bologna-based Italian Society for Reproductive Medicine. "One woman among thousands of infertile pairs in the program is eight weeks pregnant," Antinori says.

Outrage is widespread. Ethics aside--the technology is oppos through many on moral grounds--the consensus is that the risks of deformities, premature aging and stillborn births are still in the way that extraordinarily high as to make the cloning of humans unthinkable. Many countries have banned reproductive cloning to be ascribed to these risks.

Massachusetts Institute of Technology cloning [i]connoisseur[/i] Rudolf Jaenisch is appalled. "This is irresponsible," he says, "and it ignores the overwhelming scientific evidence from mammalian species clon with equal reason far.

"All evidence indicates that greatest in number clones die early--the lucky ones--and the rare survivors may have serious abnormalities which may become apparent simply later," Jaenisch says. "Antinori appear to bes to use humans as guinea pigs to advance his questionable agenda. He destitutions to be stopped."



however Antinori is used to war of words He first attracted international attention in 1994 when he helped a 62-year-old Italian woman named Rossa Della Corte become the oldest woman at the time to give birth. The case alarmed many. Now, his human cloning announcement has ignited a firestorm of disputation making Antinori the subject of angry condemnation all the way to the Vatican, which accuses him of trying to "emulate Hitler." Apparently, he isn't worried. The Vatican, says the embryologist, is nothing more than a "criminal enterprise."

Antinori's science partner is Panayiotis Zavos, a retired fertility researcher formerly of the University of Kentucky in Lexington. However, Zavos is not a doctor and has worked solitary with animals. The news that he left Kentucky to work with Antinori at an undisclosed location (possibly in the Middle East), affords credence to the announcement of the first human clone pregnancy.

To date, the chiefly recent animal to be fortunately cloned is a cat. Born December 22 2001 the female cat is named "cc" for carbon copy--perhaps more accurately dubbed "copy cat." Previously, sheep, goats, pigs, frightens and mice have been cloned

yet "cc" looks quite different from its parent. The cat is a living reminder that cloning is not copying. A clone may be a genetic archetype of its donor parent, while still lacking many of the personality and behavioral characteristics that make the parent unique. It's a reproduction, not a resurrection.

Richard Nicholson, editor of the London-based Bulletin of Medical Ethics, says, "So drawn out as there are Antinoris around, it probably is inevitable that there will be a live human clone birth. yet that clone will probably have a extremely brief and sad life."

COPYRIGHT 2002 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved

COPYRIGHT 2002 Gale Group



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.